Trial intelligence / Profile preview

Intravenous ondansetron-induced electrocardiogram changes in postoperative patients

IRCT2016070328754N1Phase 3Completed

Sponsor
Bushehr University of Medical Sciences
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of ondansetron in postoperative nausea and vomiting (PONV), sponsored by Bushehr University of Medical Sciences. Primary endpoint: Electrocardiogram changes after intravenous ondansetron. Started Jul 2016; status: completed.

02

Drugs

ondansetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT2016070328754N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016070328754N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call